Are you Dr. Tindall?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 28 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
720 N Bay St
Suite 11
Eustis, FL 32726Phone+1 352-483-1600- Is this information wrong?
Summary
- Dr. Donald Tindall, MD is an emergency medicine physician in Eustis, Florida. He is currently licensed to practice medicine in Florida. He is affiliated with AdventHealth Orlando.
Education & Training
Loma Linda University Health Education ConsortiumResidency, Pathology-Anatomic and Clinical, 1974 - 1975
AdventHealth FloridaInternship, Transitional Year, 1972 - 1973
Loma Linda University School of MedicineClass of 1972
Certifications & Licensure
FL State Medical License 1973 - 2025
Publications & Presentations
PubMed
- 4 citationsAndrogen Mediation—and Antiandrogens Mitigation—of the Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash: Results From a Pilot Randomized Trial and Small ...Jennifer Le-Rademacher, Kendrith M. Rowland, Pamela J. Atherton, Christopher S R Dakhil, Zhifu Sun, Angelina Tan, Lucy J. Schmidt, Phuong L. Nguyen, Carmen Radecki Bre...> ;The American Journal of Hospice & Palliative Care. 2019 Jan 2
- 72 citationsAndrogen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancerYundong He, Ji Lu, Zhenqing Ye, Siyuan Hao, Liewei Wang, Manish Kohli, Donald J. Tindall, Benyi Li, Runzhi Zhu, Liguo Wang, Haojie Huang> ;Nucleic Acids Research. 2018 Feb 28
- 93 citationsHSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort studyJason W.D. Hearn, Ghada AbuAli, Chad A. Reichard, Chandana A. Reddy, Cristina Magi-Galluzzi, Kai Hsiung Chang, Rachel Carlson, Laureano J. Rangel, Kevin Reagan, Brian ...> ;The Lancet. Oncology. 2016 Oct 1
- Join now to see all
Grant Support
- Androgenic Inactivation Of FOXO1 In Prostate CancerNational Cancer Institute2007–2011
- Developemental Research ProgramNational Cancer Institute2008–2010
- Career Development ProgramNational Cancer Institute2008–2010
- Administrative CoreNational Cancer Institute2008–2010
- Coregulators In Androgen-Refractory Prostate CancerNational Cancer Institute2006–2010
- Spore In Prostate CancerNational Cancer Institute2004–2010
- Androgenic Inactivation Of FKHR In Prostate CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Coactivators In Androgen-Refractory Prostate CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2004
- Androgenic Inactivation Of FKHR In Prostate CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Coactivators In Androgen-Refractory Prostate CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
- Spore In Prostate CancerNational Cancer Institute2001–2003
- Characterization Of Early Growth Response Genes In Prostate CellsEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2000
- Characterization Of Early Growth Response Genes In Prostate CellsEunice Kennedy Shriver National Institute Of Child Health &Human Development1997
- Androgen Regulation Of Prostate GrowthNational Institute Of Diabetes And Digestive And Kidney Diseases1993–1996
- Spore In Prostate CancerNational Cancer Institute1995
- Specialized PGM Of Research Excellence/Prostate CancerNational Cancer Institute1992–1994
- Androgen Receptors In Cancerous Prostatic TissueNational Cancer Institute1989–1993
- Molecular Probes For The Androgen Receptor GeneNational Institute Of Diabetes And Digestive And Kidney Diseases1989
- Molecular Probes For The Androgen Receptor GeneNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1988
- Androgen Receptors In Cancerous Prostatic TissueNational Cancer Institute1986–1988
Hospital Affiliations
AdventHealth OrlandoOrlando, Florida
